Drug factory · FDA FEI 3002923756

Peptido, chemische und pharmazeutische Rohstoffgesellschaft mit beschränkter Haftung

Am Kraftwerk 6, Bexbach, Germany

Germany: 1

Problems found, fixed voluntarily at FDA's last inspection, Feb 26, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2012: 0 with no problems, 5 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
LevothyroxineMakes the active ingredient Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) 52652-1950

FDA inspection history

EndedResultProgramProblems noted
Feb 26, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 11, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 2, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 17, 2015Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 6, 2012Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: api manufacture.